BioCircuit Technologies
PrivateLast Round
Grant
Nov 20, 2024
Total Funding Raised
$23.46M
Company Overview
BioCircuit Technologies is a medical devices company that develops and commercializes solutions for tissue repair and neuromodulation, including its flagship sutureless nerve repair product, Nerve Tape®.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioCircuit Technologies Comps
Public and private peers based on sector, stage, and business model.
BioCircuit Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 20, 2024 | ||||
| Grant | Oct 19, 2023 | ||||
| Seed | Sep 27, 2022 | ||||
| Grant | May 4, 2021 | ||||
| Seed | Apr 22, 2021 |
BioCircuit Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| GRA Venture Fund | Seed |
| Masters Capital Management | Seed |
| Alsora Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2025
Launched the ConformaWrap nerve protector.
BioCircuit Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioCircuit Technologies's valuation, stock price, and market status.
